Close Menu

Google has invested in Navigenics, hoping to broaden its reach to include genetic information, say this Business Week article. As the media sees it, Navigenics is hoping to pull away from 23andMe (which Google also invested in). "23andMe has taken the approach of providing you a fun, social, and ancestral look at your DNA," says Amy DuRoss, head of policy and business affairs for Navigenics, whereas her company "has taken the v

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.